Financials
- Market Capitalization 2.48 B
- Employee 221
- Founded 1998
- CEO Matt Kapusta
- Website www.uniqure.com
- Headquarter Netherlands
- FIGI UNKNOWN
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1842 | IMNM Immunome, Inc. - Common Stock | 22.07 USD | -3.54% | -0.63% | +13.01% | +93.09% | 2.50 B USD | ||
| 1843 | TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 58.03 USD | +0.78% | -0.57% | -12.61% | -12.16% | 2.50 B USD | ||
| 1852 | NRIX Nurix Therapeutics, Inc. - Common stock | 23.84 USD | +1.02% | +3.70% | +24.88% | +112.67% | 2.47 B USD | ||
| 1855 | TRVI Trevi Therapeutics, Inc. - Common Stock | 17.40 USD | +0.23% | +0.46% | -0.34% | +122.51% | 2.47 B USD |
Frequently asked questions about uniQure N.V. - Ordinary Shares
What is the uniQure N.V. - Ordinary Shares stock price today?
The current price of uniQure N.V. - Ordinary Shares (QURE) is 39.25. Over the past 24 hours, the stock has changed by -2.80%. Follow the QURE chart for real-time price dynamics.
What is the stock ticker of uniQure N.V. - Ordinary Shares?
uniQure N.V. - Ordinary Shares trades under the ticker QURE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is uniQure N.V. - Ordinary Shares stock going up?
QURE has changed by -0.56% over the last week, -21.18% over the last month, and +155.37% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was uniQure N.V. - Ordinary Shares net income for the last quarter?
uniQure N.V. - Ordinary Shares reported net income of -53.53 M for the last quarter. The previous quarter showed -37.09 M, which means net income changed by -44.35%.
How many employees does uniQure N.V. - Ordinary Shares have?
As of the latest available data, uniQure N.V. - Ordinary Shares has 221 employees. Workforce size can provide additional context about the company's scale and operations.
What is uniQure N.V. - Ordinary Shares EBITDA?
uniQure N.V. - Ordinary Shares EBITDA is -50.24 M, and its EBITDA margin is -1 410.33%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy uniQure N.V. - Ordinary Shares stock?
You can buy uniQure N.V. - Ordinary Shares (QURE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in uniQure N.V. - Ordinary Shares stock?
Investing in uniQure N.V. - Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the QURE chart and related analysis on metatrader.com as part of your research.